1. Home
  2. CVGI vs MOLN Comparison

CVGI vs MOLN Comparison

Compare CVGI & MOLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Commercial Vehicle Group Inc.

CVGI

Commercial Vehicle Group Inc.

SELL

Current Price

$3.07

Market Cap

116.6M

ML Signal

SELL

Logo Molecular Partners AG

MOLN

Molecular Partners AG

N/A

Current Price

$2.53

Market Cap

103.5M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
CVGI
MOLN
Founded
2000
2004
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
116.6M
103.5M
IPO Year
2004
2021

Fundamental Metrics

Financial Performance
Metric
CVGI
MOLN
Price
$3.07
$2.53
Analyst Decision
Buy
Strong Buy
Analyst Count
2
5
Target Price
$7.50
★ $9.97
AVG Volume (30 Days)
★ 316.0K
1.7K
Earning Date
11-02-2026
10-29-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 316.18
N/A
EPS
★ 0.04
N/A
Revenue
★ $755,231,000.00
N/A
Revenue This Year
$17.64
N/A
Revenue Next Year
$6.23
N/A
P/E Ratio
$83.38
★ N/A
Revenue Growth
★ 14.06
N/A
52 Week Low
$1.41
$2.63
52 Week High
$5.88
$5.36

Technical Indicators

Market Signals
Indicator
CVGI
MOLN
Relative Strength Index (RSI) 47.28 26.89
Support Level $2.97 N/A
Resistance Level $3.21 $4.21
Average True Range (ATR) 0.27 0.12
MACD -0.01 -0.06
Stochastic Oscillator 11.49 0.41

Price Performance

Historical Comparison
CVGI
MOLN

About CVGI Commercial Vehicle Group Inc.

Commercial Vehicle Group Inc and its subsidiaries are a globalised provider of systems, assemblies, and components to international commercial vehicle markets and electric vehicle markets. It delivers real solutions to complex design, engineering, and manufacturing problems while creating positive change for customers, industries, and communities it serves. The company has its manufacturing operations in the United States, Mexico, China, the United Kingdom, the Czech Republic, Ukraine, Morocco, Thailand, India, and Australia. Organisations' products are mainly sold in North America, Europe, and the Asia-Pacific region. It has three segments: Global Seating Segment, Global Electrical systmem, and Trim Systems and Components Segment, with the majority of revenue from Global Seating Segment.

About MOLN Molecular Partners AG

Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company is currently focusing on oncology through their robust pipeline of clinical and preclinical programs, with particular attention to MP0712, the key Radio-DARPin candidate targeting DLL3 now in a Phase 1/2a trial in the United States.

Share on Social Networks: